Tuberculosis
📧 Sign up to get email alerts when something new happens for Tuberculosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Study to Evaluate the Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-exposed/-Unexposed Newborn Infants in South Africa [Phase 2]
Phase 2 trial evaluating the safety and immunogenicity of the VPM1002 vaccine versus BCG in HIV-exposed and unexposed newborns in South Afri…
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen for Children [Phase 3]
This update notes the completion of a Phase 3 trial evaluating a recombinant ESAT6-CFP10 allergen for diagnosing tuberculosis in children.
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen [Phase 3]
A Phase 3 clinical study evaluating a recombinant ESAT6-CFP10 allergen for tuberculosis has completed, according to ClinicalTrials.gov.
-
CLINICAL_TRIALS withdrawal · 2018-04-10Clinical Trial Update: A Phase II Study of H56:IC31 in Healthy Adolescents [Phase 2]
A Phase II study of the TB vaccine H56:IC31 in healthy adolescents has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: Phase 1/II, Safety and Immunogenicity Study of AERAS-404 in BCG-Primed Infants [Phase 1, Phase 2]
This update confirms completion of a Phase 1/2 study evaluating the safety and immunogenicity of the AERAS-404 vaccine in BCG-primed infants…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Tuberculosis in China
This entry notes the completion of a National Institute of Allergy and Infectious Diseases study conducted in China focused on tuberculosis.…
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Gene Expression in HIV and Tuberculosis Co-infection
The document reports a completed clinical trial update from NIAID examining gene expression in HIV and tuberculosis co-infection.
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali
The terminated trial assessed the MODS test for diagnosis of multidrug-resistant tuberculosis and for second-line antituberculous drug susce…
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Multi-Drug Resistant Tuberculosis in Korea
A completed clinical trial update investigating multi-drug resistant tuberculosis in Korea.
-
CLINICAL_TRIALS research · 2018-04-05Clinical Trial Update: Collection of Tissue Specimens in Mali, West Africa, for HIV and Tuberculosis Research
A terminated Mali tissue-sample collection study for HIV and tuberculosis sponsored by NIAID is noted in this clinical trial update.
-
CLINICAL_TRIALS trial_result · 2018-04-04Clinical Trial Update: Test and Treat TB: A Proof of Concept Trial in South Africa [NA]
The document reports the completion of the Test and Treat TB proof-of-concept trial in South Africa, sponsored by Massachusetts General Hosp…
-
CLINICAL_TRIALS research · 2018-03-22Clinical Trial Update: Determining the Impact of Enhanced Case Finding on Tuberculosis Notification in The Gambia [NA]
This completed clinical trial evaluated whether enhanced case finding changes tuberculosis notification rates in The Gambia.
-
CLINICAL_TRIALS research · 2018-03-08Clinical Trial Update: Prevalence of Chronic Kidney Disease (CKD) and Risk Factors in Sub-Saharan Africa
A completed clinical trial update examining the prevalence of chronic kidney disease in Sub-Saharan Africa and its risk factors. The study a…
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: A Blinded, Cross-sectional, Diagnostic Evaluation Study Performed in Pulmonary TB Suspects at the TB Dispensary for Sector 4 of the Marius-Nasta-Institute in Bucharest, Romania
This document reports a completed clinical trial update. It describes a blinded, cross-sectional diagnostic evaluation study conducted among…
-
CLINICAL_TRIALS research · 2018-03-07Clinical Trial Update: Establishment of a Clinical Trial Unit in Mavalane, Maputo, in Mozambique
An update announcing the establishment of a new Clinical Trial Unit in Mavalane, Maputo, Mozambique to support tuberculosis research.
-
CLINICAL_TRIALS trial_result · 2018-02-13Clinical Trial Update: Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV [Phase 2]
Phase 2 trial comparing rifampin-based versus rifabutin-based tuberculosis treatment in people with HIV; study terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2018-01-19Clinical Trial Update: Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone [Phase 3]
A Phase 3 randomized, placebo-controlled trial evaluating prednisone to prevent TB-IRIS in high-risk HIV patients undergoing antiretroviral …
-
FDA approval · 2018-01-08FDA Approved: RIFADIN IV — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Rifadin IV (rifampin) submitted by Sanofi-Aventis U.S. LLC to support the intravenous formulatio…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Evaluation of Non-Inferiority of Two Fast Follower Nucleic Acid Amplification Tests
A completed trial evaluated whether two rapid nucleic acid amplification tests are non-inferior to a reference test for detecting tuberculos…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Cell Phone Messaging to Improve Communication of Critical Laboratory Results to Patients in Rural Uganda [NA]
A completed clinical trial evaluating whether cell phone messaging can improve patient communication of critical lab results in rural Uganda…
-
CLINICAL_TRIALS trial_result · 2017-12-07Clinical Trial Update: Pharmacokinetic Issues of Moxifloxacin Plus Rifapentine [Phase 1]
Phase 1 study assessing pharmacokinetic interactions between moxifloxacin and rifapentine for tuberculosis, which has been terminated.
-
CLINICAL_TRIALS approval · 2017-11-27Clinical Trial Update: Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis
The document notes marketing approval for TMC207 (bedaquiline) to treat extensively drug-resistant or pre-XDR pulmonary tuberculosis through…
-
CLINICAL_TRIALS trial_result · 2017-11-27Clinical Trial Update: Doxycycline in Human Pulmonary Tuberculosis [Phase 2]
Phase 2 trial evaluating doxycycline for pulmonary tuberculosis has completed. The snippet does not provide efficacy or safety results.
-
CLINICAL_TRIALS research · 2017-11-17Clinical Trial Update: Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan [NA]
This clinical trial update from Aga Khan University evaluates whether mobile phone SMS messages and automated calls can improve vaccine cove…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study) [Phase 4]
This Phase 4 pharmacokinetic study evaluated optimal dosing of first-line tuberculosis and antiretroviral drugs in children and has complete…